Elevated prevalence of obesity, metabolic syndrome, and cardiovascular risk factors in bipolar disorder
about
Role of neuroinflammation in the emotional and cognitive alterations displayed by animal models of obesityReview of the evidence: prevalence of medical conditions in the United States population with serious mental illnessAll the world's a (clinical) stage: rethinking bipolar disorder from a longitudinal perspectiveNeurocognitive functioning in overweight and obese patients with bipolar disorder: data from the Systematic Treatment Optimization Program for Early Mania (STOP-EM)Cholesterol and affective morbidityPaternal transmission of complex phenotypes in inbred mice.The association of weight gain with mood symptoms and functional outcomes following a first manic episode: prospective 12-month data from the Systematic Treatment Optimization Program for Early Mania (STOP-EM).Selective deficits in erythrocyte docosahexaenoic acid composition in adult patients with bipolar disorder and major depressive disorderCholesterol, mood, and vascular health: Untangling the relationship: Does low cholesterol predispose to depression and suicide, or vice versa?Co-prescription of medication for bipolar disorder and diabetes mellitus: a nationwide population-based study with focus on gender differences.Do current screening recommendations allow for early detection of lithium-induced hyperparathyroidism in patients with bipolar disorder?Trace elements in glucometabolic disorders: an update.Prevalence of Bipolar Disorder symptoms in Primary Care (ProBiD-PC): A Canadian study.Do stroke patients have an increased risk of developing suicidal ideation or dying by suicide? An overview of the current literature.The association between mood and anxiety disorders with vascular diseases and risk factors in a nationally representative sample.Functional outcome in bipolar disorder: the big picture.Cardiovascular morbidity and mortality in bipolar disorder.Omega-3 fatty acid deficiency increases stearoyl-CoA desaturase expression and activity indices in rat liver: positive association with non-fasting plasma triglyceride levels.An Integrated Risk Reduction Intervention can reduce body mass index in individuals being treated for bipolar I disorder: results from a randomized trialUse of an electronic metabolic monitoring form in a mental health service - a retrospective file audit.Topiramate versus Valproate Sodium as Adjunctive Therapies to a Combination of Lithium and Risperidone for Adolescents with Bipolar I Disorder: Effects on Weight and Serum Lipid Profiles.Cardiovascular disease and hypertension among adults with bipolar I disorder in the United States.Evidence for accelerated vascular aging in bipolar disorder.Effect of Early Intervention with Omega-3 on Insulin Resistance in Patients Initiated on Olanzapine with either Sodium Valproate or Lithium: A randomized, Double-blind, Placebo-Controlled Trial.Distinguishing between unipolar depression and bipolar depression: current and future clinical and neuroimaging perspectives.Metabolic syndrome in bipolar disordersCan bipolar disorder be viewed as a multi-system inflammatory disease?Rapid adipose deposition with mood disorders.Elevated immune-inflammatory signaling in mood disorders: a new therapeutic target?A pilot study investigating tumor necrosis factor-α as a potential intervening variable of atypical antipsychotic-associated metabolic syndrome in bipolar disorder.White matter hyperintensities: from medical comorbidities to bipolar disorders and backCardiovascular mortality in bipolar disorder: a population-based cohort study in Sweden.General medical burden in bipolar disorder: findings from the LiTMUS comparative effectiveness trial.Psychological conditions in adults with diabetes.Manic/hypomanic symptom burden and cardiovascular mortality in bipolar disorder.Mania and mortality: why the excess cardiovascular risk in bipolar disorder?A fresh look at NASH pathogenesis. Part 1: the metabolic movers.Surgical treatment of morbid obesity among patients with bipolar disorder: a research agenda.Metabolic syndrome and bipolar disorder: what should psychiatrists know?Neurotrophins, inflammation and oxidative stress as illness activity biomarkers in bipolar disorder.
P2860
Q26802171-DAF174D7-BBED-4564-B3FC-660B3891BF0DQ26849474-AB8727AF-4894-41CF-BF69-157D720DCDB9Q26865366-EBE8B73D-8155-40BC-A1C4-42C825F86A23Q30897232-86ADE4BB-B9BC-4624-80B8-D8F9786FEF5FQ33624225-834EAD1F-5218-4731-B338-0910DC680E26Q33697424-670E33B6-5F43-4D29-8E9E-2B8DF6F1CEA9Q33702652-1CE7A04F-8F20-4CE5-B183-6D8C76484432Q34065537-D5604FCF-BBDD-4288-9DE0-4398B339FAEFQ34432313-A308DF13-1FA4-4CD7-8A2B-2875306A597BQ34491836-C8161425-F1F9-4924-8CBE-635D34B76DA7Q34503303-AFA28FF8-7437-4404-9E88-52A01FF1DE46Q34504189-5BBA7B55-6C97-4ED2-B3CD-FEE44D19D70CQ34573426-328DD841-4484-41CA-8B97-862BA86D0ED9Q34642046-B3B80351-F166-48AA-A646-DC3F7FD5C8C3Q34644143-2DEC9DF7-ACD7-4F0C-8C67-9B2AB05C515DQ35233996-F5750284-3CD6-4636-823C-045A7865A0E0Q35313130-864E5F4F-3943-4476-A543-DF6FD8263FF4Q35633941-4FE3F977-58E2-4092-A3A1-084EFAD15A21Q35690464-9BB6B934-8626-4E28-9648-C792375497CEQ35994346-4B427509-E7C1-48F1-B921-EAEE55D44056Q36092635-2AAE81D3-3428-42E1-ABF2-915D539A2F4CQ36108130-9CB28756-FCFF-4715-B072-76E5F99D2988Q36134990-592DCED1-5F53-4AD9-932A-A488A99B34B6Q36197756-07D8959E-3875-42DA-8BFA-EE10BC8D922DQ36388848-7F370BD4-C185-4E0A-8A96-7D354F631B79Q36400968-BB84F573-0120-4CBE-8DEB-5BBB816C9540Q36401142-20880345-AC68-46B7-8F8A-D7C5FBDAA677Q36417680-3EE7CFD6-68C2-409D-84A1-05B9D57DBC84Q36502629-6B82E91B-1D1E-454A-BAD5-ADF13F8FF083Q36759102-EAC8BEFA-2647-418A-A759-6732394022CDQ36798672-845BFEAD-A721-4BD1-81B9-81182F08950CQ36810120-26BF4A15-4485-425F-B7D1-7DA3324AD438Q37213547-13C4C67F-F55F-405C-BC80-CF5EAD89CD3AQ37333831-74B61227-C896-43B1-AD95-2655D4AA0D9AQ37426682-42C7983E-0029-47E5-87DE-62CE6D558A0EQ37631787-8F4943FB-BD74-46AC-B97E-B61D24E79938Q37759155-B457ECB0-3694-4322-A54C-244303E5EDB7Q37863532-069D3F11-980D-4577-8F1A-7C115A8B0E0CQ37954425-AFAEC084-1B96-4E1C-B62B-33A57C4AEF38Q38125218-8C30B7BB-255B-494C-A766-A664A97CCB9A
P2860
Elevated prevalence of obesity, metabolic syndrome, and cardiovascular risk factors in bipolar disorder
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on July 2008
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Elevated prevalence of obesity ...... sk factors in bipolar disorder
@en
Elevated prevalence of obesity ...... k factors in bipolar disorder.
@nl
type
label
Elevated prevalence of obesity ...... sk factors in bipolar disorder
@en
Elevated prevalence of obesity ...... k factors in bipolar disorder.
@nl
prefLabel
Elevated prevalence of obesity ...... sk factors in bipolar disorder
@en
Elevated prevalence of obesity ...... k factors in bipolar disorder.
@nl
P2860
P50
P921
P1476
Elevated prevalence of obesity ...... sk factors in bipolar disorder
@en
P2093
Narasimha M Palagummi
Valerie L Forman-Hoffman
P2860
P304
P356
10.1080/10401230802177722
P577
2008-07-01T00:00:00Z